• OPEN AN ACCOUNT
Indian Indices
Sensex
77,540.83 3.11
( 0.00%)
Global Indices
Nasdaq
53,294.39 514.18
(0.97%)
Dow Jones
7,693.51 31.35
(0.41%)
Hang Seng
65,893.13 -323.66
(-0.49%)
Nikkei 225
10,809.01 60.85
(0.57%)
Forex
USD-INR
95.63 -0.07
(-0.07%)
EUR-INR
111.19 0.41
(0.37%)
GBP-INR
129.81 0.28
(0.22%)
JPY-INR
0.60 0.00
(0.43%)

EQUITY - MARKET SCREENER

Venus Remedies Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
526953
INE411B01019
515.9180123
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VENUSREM
20.44
2313.02
EPS(TTM)
Face Value()
Div & Yield %
84.64
10
0.58
 

Vasudhagama Enterprises reports consolidated net loss of Rs 0.06 crore in the March 2026 quarter
Jun 01,2026
Net loss of Vasudhagama Enterprises reported to Rs 0.06 crore in the quarter ended March 2026 as against net profit of Rs 0.07 crore during the previous quarter ended March 2025. Sales reported to Rs 0.13 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025.

For the full year,net profit declined 99.44% to Rs 0.01 crore in the year ended March 2026 as against Rs 1.80 crore during the previous year ended March 2025. Sales declined 95.62% to Rs 1.13 crore in the year ended March 2026 as against Rs 25.77 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.130 0 1.1325.77 -96
OPM %46.150 -47.7910.21 -
PBDT0.060.12 -50 0.543.11 -83
PBT-0.080.09 PL -0.062.36 PL
NP-0.060.07 PL 0.011.80 -99